SAIA Hypertension
Undiagnosed and untreated hypertension is one of the largest drivers of cardiovascular disease, which contributes to one third of deaths globally.
Hypertension in Mozambique
Hypertension disproportionately affects low and middle income countries. A systematic review across sub-Saharan Africa reported hypertension prevalence between 14.7-69.9% (median prevalence 29%). In Mozambique (a low-income country with >13% adult HIV prevalence), hypertension prevalence among adults increased sharply from 2005 to 2015, now affecting nearly 40% of adults. Yet just 14.5% are aware of their hypertension status (the lowest in sSA); among these, only 50.1% are in treatment, less than half of whom have controlled hypertension. As a result of this leaky cascade, only 3% of the adult population with hypertension in Mozambique have their condition controlled.
Low-cost, systems-level interventions like SAIA are effective and efficient approaches to improve linked cascade services. They also may be effective for routinizing hypertension diagnosis and management within existing outpatient services, for addressing both individual and systems-level barriers, for improving flow through the hypertension cascade, and ultimately improving patient-level outcomes.
Update: In 2020 the on-going SAIA-HTN received supplemental funding to “scale out” and “scale up” SAIA-HTN in one additional province, serving as a foundation for national scale-up. For more information, please visit the SCALE SAIA-HTN study page below.
Recent Publications and Posters
Study Location
SAIA-HTN is currently being implemented in 16 health facilites across Manica and Sofala provinces in central Mozambique.
SAIA-HTN Team
Additional Team Members:
Kenneth Sherr, PhD | Co-Investigator | ksherr@uw.edu
Bryan Weiner, PhD | Co-Investigator | bjweiner@uw.edu
Kristjana Asbjornsdottir | Co-Investigator | kasbjorn@uw.edu
Nona Sotoodenhia | Co-Investigator | nsotoo@uw.edu
James Pfeiffer | Co-Investigator | jamespf@uw.edu